Monday, August 03, 2026 | 08:51 PM ISTहिंदी में पढें
Samsung Biologics
Samsung Biologics to acquire PolyPeptide in $1.8 billion deal
Shares of Samsung Biologics declined as much as 3.3% in Seoul on Monday. PolyPeptide shares jumped as much as 5.6%
 "Samsung Biologics to acquire PolyPeptide in $1.8 billion deal")
Updated On : 20 Jul 2026 | 11:53 PM IST
Samsung's pharma branch fined for accounting breach worth $4 bn
Contract drugmaker Samsung BioLogics is the third-biggest firm of its kind in the world by market share, and one of the South's 10 most valuable companies
 "Samsung's pharma branch fined for accounting breach worth $4 bn")
Updated On : 14 Nov 2018 | 4:04 PM IST
Samsung BioLogics stocks dip after regulators claim accounting rules breach
Shares in the $30 billion company, an affiliate of technology giant Samsung Electronics Co Ltd, plunged almost 20 percent amid suspicion it breached accounting rules to inflate its net profit
 "Samsung BioLogics stocks dip after regulators claim accounting rules breach")
Updated On : 03 May 2018 | 12:28 AM IST